IKARI CATHETER Trademark

Trademark Overview


On Tuesday, January 16, 2024, a trademark application was filed for IKARI CATHETER with the United States Patent and Trademark Office. The USPTO has given the IKARI CATHETER trademark a serial number of 98358856. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 15, 2024. The IKARI CATHETER trademark is filed in the Medical Instrument Products category with the following description:

Intracardiac catheters; medical catheters; surgical catheters; tubing for use with catheters; hydrophilic guide wire to track catheters
ikari catheter

General Information


Serial Number98358856
Word MarkIKARI CATHETER
Filing DateTuesday, January 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, August 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesIntracardiac catheters; medical catheters; surgical catheters; tubing for use with catheters; hydrophilic guide wire to track catheters

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 16, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressTokyo 157-0066
JP

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024NEW APPLICATION ENTERED
Friday, May 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 12, 2024ASSIGNED TO EXAMINER
Thursday, August 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 15, 2024NON-FINAL ACTION E-MAILED
Thursday, August 15, 2024NON-FINAL ACTION WRITTEN